Objectives: To evaluate the different therapeutic possibilities for treating Sleep Apnea/ Hypoapnea Syndrome (SAHS), as well as the effectiveness of such treatments, and to evaluate the epidemiological and clinical aspects of this syndrome. Study design: We carried out a meta-analytical, observational and retrospective study by selecting a total of 13 articles, which provided a sample size of 642 diagnosed cases of SAHS. Results: SAHS was more prevalent among males (88.7%) and the average age of diagnosis was 49.75 years old. In the majority of cases, these patients were found to be overweight, with an average body mass index of 28.32 Kg/ m². The average apnea / hypoapnea index was 31.64 apneas / hypoapneas per hour, which is therefore considered to be a moderate type of SAHS. The therapeutic approach involved intraoral mandibular advancement devices in 77.96% of the cases, followed by 16% of the patients who were treated with continuous positive airway pressure devices during sleep (CPAP), and lastly, 7% underwent surgical treatment. Conclusions: SAHS is a complex clinical condition that requires a multidisciplinary team in order to diagnose and treat it. There are several therapeutic possibilities available to professionals, which have obtained highly satisfactory results.
Introduction
Obstructive sleep apnea syndrome (OSAS) is a hidden and potentially deadly sleep disorder in which there is a high incidence, and it is a very important public health issue as well as a social issue. OSAS is characterized by a periodic collapse of the upper airways while sleeping, mainly during the REM phase, which causes an absence (apnea) or decrease (hypoapnea) of the airflow in the lungs despite the patient´s persistent respiratory effort. The prevalence of OSAS in western countries affects approximately 5% of adults, ranging from 3 to 10% of the male population in Spain, compared to 2% of the female population (1) . An adequate clinical history and an exhaustive physical exam will enable identifying patients who suffer OSAS. Polysomnography is used as the primary method for diagnosing SAHS, and is often used in conjunction with a lateral teleradiography of the head followed by a cephalometric study, which is a good indicator for defining and identifying where the obstruction is and even for helping to decide the therapeutic course of treatment to follow (1) (2) (3) (4) . The apnea-hypoapnea index (AHI) is used by many professionals for confirming the diagnosis and quantifying the severity of the sleep disorder. The AHI is calculated by adding up the number of apneas (breathing interruptions lasting 10 seconds of more) and hypoapneas (the decrease, but not the complete interruption of the air flow which causes a 3% drop in oxygen saturation or sleep disturbances) during the study, divided by the number of hours slept (1) (2) (3) (4) (5) . As for treatment, first, one must take a series of general steps towards losing weight, getting rid of habits such as using alcohol, tobacco or maintaining an irregular schedule, and must decrease the use of hypnotic or sedative drugs. Medical treatment consists of the CPAP, which is based on a high pressure device that releases an intense and continuous flow of air through a nose mask that the patient must wear while sleeping. In the dental treatment, there are a number of intraoral devices which, according to their mechanism of action, can be classified as: tongue retaining device (TRD), adjustable soft palate lifter (ASPL) and repositioning of the uvula, and mandibular advancement devices (MAD). The surgical alternatives vary greatly and range from a tracheostomy, surgery of the nasal passages, uvulopalatopharyngoplasty, surgery on the geniohyoid complex, glossectomy, and orthognathic surgery. The objectives of our study are to evaluate the different therapeutic possibilities for treating OSAS as well as the effectiveness of these treatments, and to evaluate the clinical and epidemiological aspects of this syndrome.
Material and Methods
A meta-analytical, observational and retrospective study was carried out based on the results obtained from a bibliographic search in PubMed. The key words used were: "Sleep apnea syndrome", "obesity", "cephalometric analysis", and "positive pressure ventilation". We reviewed a total of 30 articles, ranging from the year 1996 to 2009, which had to meet the following established criteria in order to be included: articles that present more than 10 clinical cases of OSAS diagnosed by polysomnigraphy and/or cephalometric study, and that evaluate both the treatment used as well as its effectiveness. The 13 articles selected provided a sample size of 642 cases, which were treated using descriptive statistics to evaluate the following parameters (Table 1) : Age: The age of the subjects was recorded at the time of the diagnosis. Sex: The sex of the patient was recorded and a comparison between the occurrences of this disorder with respect to gender was also evaluated. Type of OSAS: The subjects were categorized into groups and the frequency of occurrence was evaluated in each group, comparing it with the apnea/ hypoapnea index. Apnea/ Hypoapnea Index (AHI): The average of all of the subjects was recorded as well as their ranges, and then compared with the type of apnea. Body Mass Index (BMI): The average for all of the patients was obtained, as well as the ranges, and the degree of obesity was compared with the type of OSAS. Treatment: The most common therapeutic approach used for the different patients as well as the effectiveness of such treatment was analyzed.
Results
The results of the population studied was variable according to each parameter indicated, given that it was impossible to obtain all of the data on each one of the individuals, projecting the following results: With respect to the age variable, there were 539 patients evaluated at the time of the diagnosis, ranging in age from 23 to 78 years old (a range of 55 years), with the average age of diagnosis being 49.74 years old. As far as the patient´s sex, the OSAS in the population studied was more prevalent among males, reporting 362 cases and accounting for 88.7% of the group, compared to 11.27% or 46 cases among females. The ratio was 7.86 males per female (Fig. 1) . As far as the type of OSAS, 391 patients were diagnosed with moderate OSAS, representing 45.7% of the group and making it the most prevalent type, which is consistent with the AHI as can be observed below. The severe type of OSAS comes in second place in terms of prevalence and accounts for 36.1% of the population studied; lastly, those who suffer a mild type represent 18.2% of the cases. Based on the classification used by the WHO, we were able to observe that the majority of the subjects were overweight. For 76.94% of the patients or in 494 cases, the most common therapeutic approach involved the use of intraoral devices designed to produce a mandibular advancement. A total of 103 subjects or 16% of the patients were treated with CPAP (continuous positive airway pressure devices during sleep), whereas 7% (45 patients) underwent a mono or bimaxillary orthognathic surgery and/ or genioplasties. As for the effectiveness of the treatments, we were able to observe that the surgical treatment obtained an 85.56% success rate, followed by an 84.35% success rate in treatment using CPAP, whereas treatment with intraoral mandibular advancement devices were successful in 73.94% of the cases (Fig. 2 ).
Discussion
From a clinical perspective, OSAS is characterized by the triad of daytime fatigue (hypersomnia), snoring and pauses in breathing at night which is generally referred by the spouse or partner. These symptoms are simultaneously present in almost all those affected by this sleep disorder. In addition, other neuropsychiatric and cardiorespiratory disorders are common, which are secondary to the constant oxygen desaturations and to the temporary and subconscious sleep disturbances that are caused by the apneas (1).
As for the age of the patient when diagnosed with OSAS, authors such as Tegelberg et al. (6) consider the most common period to be between the fourth and fifth decades of life, an assertion that is consistent with our study in which the patients averaged 49.74 years of age when they were diagnosed. Despite this, authors such as Cohen (4) set a fairly large age range that usually goes from 23 to 78 years old.
As for the sex of the patient, there is a consensus among the authors consulted, supported by the fact that 88.7% of the subjects included in our study were male, compared to 11.3% who were female (7-16). There are various studies in which all of the patients were male, such as the case reported by Battagel et al. (3) . Only the study by Van Haute et al. (17) contrasts the previous results, given that among their patients diagnosed with OSAS associated with metabolic disorders, particularly acromegaly, they estimate a slightly higher percentage (57.41%) in females compared with males. Clinically, OSAS can be divided into three categories described by the American Sleep Apnea Association, and are closely connected to the AHI; they are classified as: mild form when the AHI is between 5 and 20, moderate form if it is between 21 and 40, and severe form if it is more than 40. Based on this classification, when evaluating the prevalence of each one of the clinical forms in our study, we found that the most common type is moderate OSAS, which accounts for 45.7% of the cases. In this respect, it is worth noting that in the study conducted by Bruno Carlo et al. (12) , patients who had an average AHI of 35 apneas/ hypoapneas per hour were classified as having a severe OSAS, which is why based on the classification previously mentioned, we decided to group it with the moderate type.
As for the apnea/ hypoapnea index (AHI), both our study as well as the rest of the literature agrees that this variable is the one to be used for diagnosing OSAS, given that an AHI above 5 apneas/ hypoapneas per hour is considered to be pathological (1-3).
As for the body mass index (BMI), it should be noted that the majority of these patients present a problem associated with obesity, sometimes in combination with the use of alcohol and tobacco. In our case, all of the authors selected for our study presented subjects who 
